Ankylosing spondylitis trials in Italy

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  Where

  Florence, Reggio Emilia

  People

  339 worldwide

  Run by

  Novartis Pharma AG

  See details and how to joinNCT04638647 · EU 2023-504417-67-00
• No phaseTaking people
  Exactech Shoulder Post Market Clinical Follow-up Study

  Where

  Catania, Eboli

  Age

  21 years and over

  People

  20,000 worldwide

  Run by

  Exactech

  See details and how to joinNCT05603728